NCT07459660Phase 2Enrolling by invitation

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

Study sponsor: MapLight Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-03Estimated
Enrollment · participants210Estimated
Source updated2026-11-12Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Enrolling by invitation.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source